JAK Inhibitors Prior to Allogeneic Stem Cell Transplant for Patients with Myelofibrosis: A Prospective Study

被引：0
|
作者：
Salit, Rachel B. [1 ]
Stevens, Emily [2 ]
Baker, Kelsey [1 ]
Scott, Bart L. [3 ]
Gooley, Ted Alan [1 ]
Deeg, H. Joachim [4 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, Transplantat Biol, 1124 Columbia St, Seattle, WA 98104 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Transplantat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [31] Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis
    Palmer, Jeanne
    Kosiorek, Heidi E.
    Wolschke, Christine
    Fauble, Veena D. S.
    Butterfield, Richard, III
    Geyer, Holly
    Scherber, Robyn M.
    Dueck, Amylou C.
    Gathany, Allison
    Mesa, Ruben A.
    Kroger, Nicolaus
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2267 - 2273
  • [32] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    M Ditschkowski
    D W Beelen
    R Trenschel
    M Koldehoff
    A H Elmaagacli
    Bone Marrow Transplantation, 2004, 34 : 807 - 813
  • [33] Outcome of allogeneic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Beelen, DW
    Trenschel, R
    Koldehoff, M
    Elmaagacli, AH
    BONE MARROW TRANSPLANTATION, 2004, 34 (09) : 807 - 813
  • [34] Pre-Transplantation Predictors of Survival in Patients Undergoing Allogeneic Stem Cell Transplant for Myelofibrosis
    Palmer, Jeanne
    Jain, Tania
    Kunze, Katie L.
    Partain, Daniel K.
    Khera, Nandita
    Sproat, Lisa
    Noel, Pierre
    Slack, James L.
    Roy, Vivek
    Leis, Jose F.
    Hogan, William J.
    Tefferi, Ayalew
    Fauble, Veena D. S.
    Patnaik, Mrinal M.
    Kosiorek, Heidi Elizabeth
    Mesa, Ruben A.
    BLOOD, 2017, 130
  • [35] ROLE OF EXTENSIVE SPLENOMEGALY IN PATIENTS WITH MYELOFIBROSIS UNDERGOING A REDUCED INTENSITY ALLOGENEIC STEM CELL TRANSPLANT
    Ciurea, S. O.
    Sadegi, B.
    Wilbur, A.
    Alagiozian-Angelova, V.
    Gaitonde, S.
    Dobogai, L.
    Akard, L. P.
    Hoffman, R.
    Rondelli, D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 112 - 112
  • [36] APPLICATION OF THE MYELOFIBROSIS TRANSPLANT SCORE (MTSS) IN ALLOGENEIC STEM CELL TRASPLANTATION FOR PRIMARY AND SECONDARY MYELOFIBROSIS
    Chiusolo, P.
    Sora, F.
    Metafuni, E.
    Giammarco, S.
    Di Giovanni, A.
    Rossi, E.
    Za, T.
    Laurenti, L.
    Innocenti, I.
    Autore, F.
    De Stefano, V.
    Bacigalupo, A.
    Sica, S.
    HAEMATOLOGICA, 2019, 104 : 84 - 85
  • [37] A retrospective study of patients treated with imatinib mesylate prior to allogeneic hematopoietic stem cell transplant.
    Oehler, VG
    Gooley, T
    Snyder, DS
    Forman, SJ
    Radich, JP
    BLOOD, 2004, 104 (11) : 753A - 753A
  • [38] Outcome in Pediatric Patients with a History of Fungal Disease Prior to Allogeneic Stem Cell Transplant
    Aftandilian, Catherine
    Agarwal, Rajni
    Kharbanda, Sandhya
    Weinberg, Kenneth I.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S165 - S165
  • [39] Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients
    Martin-Pena, Almudena
    Aguilar-Guisado, Manuela
    Espigado, Ildefonso
    Parody, Ricardo
    Cisneros, Jose Miguel
    CLINICAL TRANSPLANTATION, 2011, 25 (03) : 468 - 474
  • [40] Splenic irradiation prior to allogeneic hematopoietic cell transplantation for patients with myelofibrosis
    John R. Bales
    Haesook T. Kim
    Roxana Portillo
    Chirayu Patel
    Steven McAfee
    Bimalangshu Dey
    Thomas Spitzer
    Yi-Bin Chen
    Areej El-Jawahri
    Zachariah DeFilipp
    Gabriela S. Hobbs
    Bone Marrow Transplantation, 2023, 58 : 459 - 461
12345